BioNTech SE (BNTX)
USD 98.18
(-0.08%)
USD 98.18
(-0.08%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -11.44 Billion EUR | 16.24% |
| 2022 | -13.66 Billion EUR | -882.09% |
| 2021 | -1.39 Billion EUR | -43.42% |
| 2020 | -970.02 Million EUR | -115.44% |
| 2019 | -450.24 Million EUR | -26.02% |
| 2018 | -357.27 Million EUR | -193.43% |
| 2017 | -121.75 Million EUR | 56.05% |
| 2016 | -277.01 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -10.12 Billion EUR | -15.81% |
| 2024 Q1 | -8.74 Billion EUR | 23.63% |
| 2023 Q3 | -13.29 Billion EUR | 4.78% |
| 2023 FY | -11.44 Billion EUR | 16.24% |
| 2023 Q4 | -11.44 Billion EUR | 13.91% |
| 2023 Q2 | -13.96 Billion EUR | -16.98% |
| 2023 Q1 | -11.93 Billion EUR | 12.65% |
| 2022 Q1 | -5.97 Billion EUR | -329.71% |
| 2022 FY | -13.66 Billion EUR | -882.09% |
| 2022 Q4 | -13.66 Billion EUR | -3.9% |
| 2022 Q3 | -13.14 Billion EUR | -44.57% |
| 2022 Q2 | -9.09 Billion EUR | -52.15% |
| 2021 Q2 | -657.3 Million EUR | -3.2% |
| 2021 Q1 | -636.9 Million EUR | 46.97% |
| 2021 FY | -1.39 Billion EUR | -43.42% |
| 2021 Q4 | -1.39 Billion EUR | 33.94% |
| 2021 Q3 | -2.1 Billion EUR | -220.4% |
| 2020 Q4 | -1.2 Billion EUR | -47.4% |
| 2020 Q3 | -814.84 Million EUR | -62.09% |
| 2020 Q2 | -502.72 Million EUR | -30.59% |
| 2020 Q1 | -384.95 Million EUR | 14.5% |
| 2020 FY | -970.02 Million EUR | -115.44% |
| 2019 FY | -450.24 Million EUR | -26.02% |
| 2019 Q4 | -450.24 Million EUR | -13.84% |
| 2019 Q3 | -395.49 Million EUR | -76.91% |
| 2019 Q1 | 411.83 Million EUR | 215.27% |
| 2019 Q2 | -223.55 Million EUR | -154.28% |
| 2018 FY | -357.27 Million EUR | -193.43% |
| 2018 Q4 | -357.27 Million EUR | 0.0% |
| 2018 Q1 | 172.35 Million EUR | 0.0% |
| 2017 FY | -121.75 Million EUR | 56.05% |
| 2016 FY | -277.01 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Agenus Inc. | 274.13 Million USD | 4274.789% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 66337.991% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 1822488.535% |
| Acelyrin, Inc. | -216.9 Million USD | -5176.368% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 7175.837% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -47512.431% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -9677.865% |
| IO Biotech, Inc. | -140.69 Million USD | -8034.102% |
| Ardelyx, Inc. | 34.51 Million USD | 33261.219% |
| Geron Corporation | 14.76 Million USD | 77632.687% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -10253.637% |
| Innoviva, Inc. | 255.56 Million USD | 4578.191% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -233035.058% |
| ChromaDex Corporation | -24.04 Million USD | -47490.652% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -68067.252% |
| Onconetix, Inc. | 5.33 Million USD | 214762.576% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -179310.566% |
| GlycoMimetics, Inc. | -40.98 Million USD | -27824.264% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -7324.52% |
| Vaxcyte, Inc. | -368.22 Million USD | -3008.028% |
| Pharming Group N.V. | 109.8 Million USD | 10522.753% |
| ContextLogic Inc. | -232 Million USD | -4833.017% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -150566.14% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 112356.989% |
| AlloVir, Inc. | -62.69 Million USD | -18155.28% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -61696.377% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -111948.169% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -203893.856% |
| Summit Therapeutics Inc. | 34.67 Million USD | 33106.287% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -168128.723% |
| Senti Biosciences, Inc. | 1.74 Million USD | 657835.632% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -188692.478% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 166093.724% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 94191.497% |
| PDS Biotechnology Corporation | -32.7 Million USD | -34889.254% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 91576.301% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -6702.827% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -4622.09% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -65688.687% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | -2934.166% |
| Elevation Oncology, Inc. | -19.11 Million USD | -59762.956% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 18782.926% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 11471198.237% |
| AbCellera Biologics Inc. | -55.94 Million USD | -20358.706% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -493834.684% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -161091.549% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -663739.907% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -8763.95% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -61696.377% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -20386.539% |
| ESSA Pharma Inc. | -33.62 Million USD | -33939.443% |
| Vaxxinity, Inc. | 10.13 Million USD | 113054.994% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -195200.341% |
| Structure Therapeutics Inc. | -124.33 Million USD | -9104.351% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -82496.709% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -6099.44% |
| Lantern Pharma Inc. | -21.7 Million USD | -52632.126% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -37472.554% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -22562.126% |
| Opthea Limited | 28.15 Million USD | 40745.023% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -6431.188% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -14676.568% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 250528.884% |
| Molecular Templates, Inc. | 707 Thousand USD | 1618855.304% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -9186815.513% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 10422.54% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 86546.106% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -16784.174% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -39539.097% |
| ADMA Biologics, Inc. | 90.06 Million USD | 12806.904% |
| Alkermes plc | -166.73 Million USD | -6763.781% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 712.031% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -15191712.462% |
| AnaptysBio, Inc. | -18.15 Million USD | -62952.173% |
| Aptorum Group Limited | 1.35 Million USD | 843446.504% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 267497.196% |
| Bicycle Therapeutics plc | -481.46 Million USD | -2277.027% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 31747.264% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -20478.631% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 81376.898% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -50776.195% |
| Chimerix, Inc. | -25.51 Million USD | -44750.884% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -8435.714% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 164343.329% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -48236.36% |
| CRISPR Therapeutics AG | -150.84 Million USD | -7486.993% |
| Precision BioSciences, Inc. | -85.41 Million USD | -13299.602% |
| Dyadic International, Inc. | -6.37 Million USD | -179335.91% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -71729.536% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 18659.011% |
| Fortress Biotech, Inc. | 7.66 Million USD | 149409.85% |
| Fortress Biotech, Inc. | 7.66 Million USD | 149409.85% |
| GT Biopharma, Inc. | -1.02 Million USD | -1120820.666% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -123797.026% |
| ImmuCell Corporation | 10.99 Million USD | 104231.163% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -133861.89% |
| Immix Biopharma, Inc. | -17.5 Million USD | -65261.146% |
| Incyte Corporation | -3.17 Billion USD | -260.45% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -136177.685% |
| Jaguar Health, Inc. | 29.39 Million USD | 39039.131% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 214538.823% |
| Keros Therapeutics, Inc. | -316.7 Million USD | -3513.67% |
| MiMedx Group, Inc. | -33.9 Million USD | -33658.886% |
| MEI Pharma, Inc. | -3.7 Million USD | -308796.086% |
| Mesoblast Limited | 55.96 Million USD | 20550.298% |
| Novavax, Inc. | -298.29 Million USD | -3736.685% |
| NextCure, Inc. | -6.47 Million USD | -176596.001% |
| Precigen, Inc. | -481 Thousand USD | -2379234.719% |
| PureTech Health plc | -167.19 Million USD | -6744.979% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 41277.994% |
| Seer, Inc. | -4.24 Million USD | -269819.811% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | -3795.915% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -36983.144% |
| Aptose Biosciences Inc. | -8.19 Million USD | -139555.884% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -365656.924% |
| Soligenix, Inc. | -4.95 Million USD | -231029.472% |
| Century Therapeutics, Inc. | 847 Thousand USD | 1351292.444% |
| Kura Oncology, Inc. | -20.11 Million USD | -56787.365% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -27864.13% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 628339.085% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -357879.356% |
| Autolus Therapeutics plc | -186.59 Million USD | -6033.259% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -23112.315% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | -4049.691% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 33497.339% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 7062.791% |
| GRI Bio, Inc. | -1.79 Million USD | -637837.57% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -127302.22% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -34312.605% |
| IGM Biosciences, Inc. | -72.6 Million USD | -15662.609% |
| INmune Bio, Inc. | -25.41 Million USD | -44937.976% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 7681.666% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -22491.442% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -70331.03% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -396603.416% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 30205.485% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -27688.272% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 35993.367% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 3128.064% |
| Verastem, Inc. | -37.27 Million USD | -30600.681% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -126039.094% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -21967.41% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -75516.782% |
| Histogen Inc. | -7.48 Million USD | -152759.623% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -52867.535% |
| Surrozen, Inc. | -32.66 Million USD | -34937.35% |
| Organovo Holdings, Inc. | -1.5 Million USD | -759329.33% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -272164.367% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 60461.152% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 437584.709% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 275475.361% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -136451.667% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -26244.551% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -78412.108% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | -3512.689% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -1584892.937% |
| Apollomics, Inc. | -27.39 Million USD | -41676.237% |
| Amarin Corporation plc | -191.04 Million USD | -5890.683% |
| Turnstone Biologics Corp. | -14.58 Million USD | -78373.67% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -45149.881% |
| Synaptogenix, Inc. | -28.66 Million USD | -39830.223% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -1222613.675% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 23584.774% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -1327442.748% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -157407.212% |
| Exelixis, Inc. | -73.05 Million USD | -15566.804% |
| Better Therapeutics, Inc. | -860 Thousand USD | -1330667.442% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -47560.017% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -4641.498% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 1554933.398% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -153763.838% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 912747.528% |
| Gritstone bio, Inc. | 39.49 Million USD | 29081.008% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -13508.162% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -434702.1% |
| Avid Bioservices, Inc. | 169.72 Million USD | 6842.906% |
| Insmed Incorporated | 721.62 Million USD | 1685.959% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -125093.732% |
| MediWound Ltd. | -5.32 Million USD | -214943.217% |
| OmniAb, Inc. | 9.2 Million USD | 124457.275% |
| Alector, Inc. | -35.63 Million USD | -32014.376% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 13412.163% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -232136.201% |
| Zai Lab Limited | -775 Million USD | -1376.723% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 3460.573% |
| Aura Biosciences, Inc. | -21.52 Million USD | -53068.873% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -13775.606% |
| Immunic, Inc. | -45.34 Million USD | -25141.729% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -5823.246% |
| Veracyte, Inc. | -203.82 Million USD | -5514.942% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 1893.0% |
| FibroGen, Inc. | 56.76 Million USD | 20260.657% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 128618.81% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -404720.235% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -552686.295% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 349.319% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -342450.135% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -6795.833% |
| TG Therapeutics, Inc. | 17.86 Million USD | 64172.332% |
| Galecto, Inc. | -21.21 Million USD | -53843.25% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -48016.88% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 829.234% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -46666.1% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -99357.721% |
| XBiotech Inc. | -200.02 Million USD | -5621.642% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -13508.162% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 252851.767% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -32354.981% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -14721.156% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 201199.982% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -6615.723% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -12289.417% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 1654.411% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -106187.864% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -17251.871% |
| NexImmune, Inc. | -3.13 Million USD | -365117.097% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -331370.718% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -75634.625% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -42130.996% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -127401.475% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -28108.124% |
| Ainos, Inc. | 4.07 Million USD | 280747.427% |
| Pluri Inc. | 22.82 Million USD | 50231.85% |
| Prothena Corporation plc | -608.34 Million USD | -1781.262% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -9537.071% |
| Celularity Inc. | 65.19 Million USD | 17655.76% |
| Rallybio Corporation | -24.1 Million USD | -47384.026% |
| Cue Biopharma, Inc. | -33.81 Million USD | -33740.74% |
| MeiraGTx Holdings plc | -40.3 Million USD | -28297.102% |
| Omeros Corporation | 331.17 Million USD | 3555.746% |
| Humacyte, Inc. | -22.48 Million USD | -50796.558% |
| Immunocore Holdings plc | -358.59 Million USD | -3091.52% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -46470.092% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -36936.342% |
| Blueprint Medicines Corporation | 702.83 Million USD | 1728.346% |
| CalciMedica, Inc. | -5.53 Million USD | -206854.792% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -5980.438% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -28485.059% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -34316.744% |
| Pulmatrix, Inc. | -10.41 Million USD | -109764.644% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -191377.33% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -29905.244% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -10173.245% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -18992.149% |
| Cytokinetics, Incorporated | 642.37 Million USD | 1881.616% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -196441.302% |
| Nutriband Inc. | -251.65 Thousand USD | -4547597.859% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -33443.187% |
| Vor Biopharma Inc. | 4.3 Million USD | 266253.488% |
| Roivant Sciences Ltd. | -6.03 Billion USD | -89.607% |
| Evogene Ltd. | -19.63 Million USD | -58189.702% |
| ProKidney Corp. | -56.23 Million USD | -20251.021% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -23413.725% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 939.107% |
| CorMedix Inc. | -43.05 Million USD | -26482.89% |
| BioLineRx Ltd. | 7.33 Million USD | 156105.998% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -41569.762% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 24900.312% |
| Atai Life Sciences N.V. | -28.55 Million USD | -39974.935% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 513189.047% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -50060.414% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 64631.153% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -15144.426% |
| MediciNova, Inc. | -50.78 Million USD | -22436.053% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -14422.683% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -50876094.71% |
| GeoVax Labs, Inc. | -6.45 Million USD | -177264.466% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -5627.426% |
| Biomea Fusion, Inc. | -166.57 Million USD | -6770.745% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -6294.524% |
| Mereo BioPharma Group plc | -51.46 Million USD | -22135.909% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -11966.762% |
| Absci Corporation | -72.59 Million USD | -15664.346% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 250748.27% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -4781.738% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -12047.838% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -11859.33% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -29190.303% |
| Allakos Inc. | -24.97 Million USD | -45724.224% |
| Imunon, Inc. | -4.21 Million USD | -271494.731% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -77532.614% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -8352.437% |
| BioAtla, Inc. | -109.01 Million USD | -10398.574% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 1554933.398% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -1218707.242% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 95742.654% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -53876.324% |
| XOMA Corporation | -29 Million USD | -39364.138% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -69009.903% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -126836.557% |
| aTyr Pharma, Inc. | -7.44 Million USD | -153539.415% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -9082.419% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -5397.877% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -13894.546% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -12237.462% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -1331931.323% |
| Akari Therapeutics, Plc | -3.84 Million USD | -297548.895% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 705298.75% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 928.792% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -963140.709% |
| UroGen Pharma Ltd. | 4.39 Million USD | 260737.668% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 10185.036% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 15903771.382% |
| Orgenesis Inc. | 21.78 Million USD | 52636.724% |
| Entera Bio Ltd. | -10.62 Million USD | -107573.347% |
| GH Research PLC | -78.07 Million USD | -14558.094% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -51248.708% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -42829.592% |
| Xencor, Inc. | 29.64 Million USD | 38706.801% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -580899.608% |
| Replimune Group, Inc. | 1.41 Million USD | 810624.079% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -4672920.073% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -8953.055% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -963140.709% |
| Portage Biotech Inc. | -4.98 Million USD | -229665.107% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -50876094.71% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -17208.309% |
| OncoCyte Corporation | -6.56 Million USD | -174280.619% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 1275387.967% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -251118.105% |
| Purple Biotech Ltd. | -14.13 Million USD | -80849.215% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -48075.619% |
| scPharmaceuticals Inc. | -6.54 Million USD | -174760.199% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -68462.706% |
| HilleVax, Inc. | -165.48 Million USD | -6815.793% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -450829.866% |
| Tharimmune, Inc. | -10.93 Million USD | -104556.896% |
| Genprex, Inc. | -6.73 Million USD | -169760.941% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | -3003.141% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -12837.599% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -816787.937% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -344934.257% |
| OKYO Pharma Limited | -826.84 Thousand USD | -1384023.805% |
| Savara Inc. | 153 Thousand USD | 7480230.719% |
| Curis, Inc. | -23.88 Million USD | -47811.416% |
| Daré Bioscience, Inc. | -5.15 Million USD | -221784.402% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -1474696.781% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -184252.448% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 965889.03% |
| BeiGene, Ltd. | -2.25 Billion USD | -407.952% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 92855.197% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | -1781.704% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -6066.737% |
| Erasca, Inc. | -37.21 Million USD | -30651.827% |
| bluebird bio, Inc. | 108.57 Million USD | 10641.121% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -888529.723% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 3121.693% |
| DBV Technologies S.A. | -126.98 Million USD | -8912.49% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -888529.723% |
| Moderna, Inc. | -2.9 Billion USD | -293.691% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -110454.482% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -105205.484% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -36381.464% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 3401.886% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -13846.285% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -12376.398% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -35362.94% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -33192.413% |
| MacroGenics, Inc. | -66.98 Million USD | -16985.318% |
| RenovoRx, Inc. | -1.17 Million USD | -975569.224% |
| Adicet Bio, Inc. | -138.78 Million USD | -8146.161% |
| Prime Medicine, Inc. | -27.94 Million USD | -40859.88% |
| Aditxt, Inc. | 18.12 Million USD | 63256.959% |
| Adagene Inc. | -87.62 Million USD | -12960.529% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -274652.078% |
| Quantum-Si incorporated | -118.55 Million USD | -9553.247% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 31886.141% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -153021.65% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -23492.735% |
| SciSparc Ltd. | -2.06 Million USD | -554117.918% |
| Vericel Corporation | 1.27 Million USD | 896309.867% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -95337.67% |
| Minerva Neurosciences, Inc. | 41 Million USD | 28010.767% |
| Generation Bio Co. | 31.44 Million USD | 36492.139% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -6426.197% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -36909.993% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 9915.855% |
| Invivyd, Inc. | -198.47 Million USD | -5666.239% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -12578.188% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -477218.096% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -16066.973% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -167586.447% |
| 2seventy bio, Inc. | 181.71 Million USD | 6398.104% |
| Clene Inc. | 3.34 Million USD | 342752.695% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -125904.34% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -53103.477% |
| GeoVax Labs, Inc. | -6.45 Million USD | -177264.466% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | -3225.72% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -43918.229% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 6541.638% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -279611.905% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 228900.48% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -219608.197% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -8683.0% |
| Evaxion Biotech A/S | 5.28 Million USD | 216573.193% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -10066.832% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -8618.167% |
| Trevena, Inc. | 2.25 Million USD | 506946.767% |
| Surrozen, Inc. | -32.66 Million USD | -34937.35% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -22118.21% |
| Cingulate Inc. | 3.08 Million USD | 371354.521% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -389569.731% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 159340.295% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -123076.411% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -14327.846% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -8606.296% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -10743.645% |
| Clearmind Medicine Inc. | -3.94 Million USD | -290177.801% |
| Kronos Bio, Inc. | -36.05 Million USD | -31642.942% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 121734.605% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 784983.621% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -20993.704% |
| Statera Biopharma, Inc. | 14.41 Million USD | 79485.944% |
| ImmunityBio, Inc. | 618.22 Million USD | 1951.206% |
| Korro Bio, Inc. | -132.94 Million USD | -8508.652% |
| Kineta, Inc. | -4.54 Million USD | -251928.188% |
| BioVie Inc. | -17.73 Million USD | -64440.793% |
| Codexis, Inc. | -43.27 Million USD | -26348.661% |
| Celularity Inc. | 65.19 Million USD | 17655.76% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -361042.316% |
| Celcuity Inc. | 6.78 Million USD | 168812.093% |
| Virax Biolabs Group Limited | -3.36 Million USD | -340012.644% |
| Cibus, Inc. | -8.07 Million USD | -141576.157% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -270521.896% |
| IN8bio, Inc. | -16.38 Million USD | -69730.984% |
| Kodiak Sciences Inc. | -103.87 Million USD | -10917.665% |
| Annexon, Inc. | -193.75 Million USD | -5806.738% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 31790655.556% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -65301.452% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -325678.537% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 1185.544% |
| Eyenovia, Inc. | 1.25 Million USD | 909338.247% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 42637.075% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -352801.634% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -34322.955% |
| Arcellx, Inc. | -296.95 Million USD | -3753.946% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -58572.203% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -19338.811% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -55115.902% |
| Moolec Science SA | 117.61 Thousand USD | 9730578.846% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -29704.422% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -30082.499% |
| Royalty Pharma plc | 5.65 Billion USD | 302.263% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -7992.575% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -163641.676% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -213304.828% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -8032.252% |
| Humacyte, Inc. | -22.48 Million USD | -50796.558% |
| 89bio, Inc. | -289.05 Million USD | -3859.343% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -45239.514% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -641773.247% |
| Genelux Corporation | -6.89 Million USD | -165787.81% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -36747.935% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 13789.877% |
| Notable Labs, Ltd. | -9.77 Million USD | -116968.331% |
| Liquidia Corporation | -80.17 Million USD | -14174.346% |
| Mustang Bio, Inc. | -3.73 Million USD | -306232.976% |
| Immunovant, Inc. | -635.22 Million USD | -1701.655% |
| Quantum-Si incorporated | -118.55 Million USD | -9553.247% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -65059.417% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -276139.44% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 142676.305% |
| Acasti Pharma Inc. | -23 Million USD | -49648.316% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -339781.843% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -70331.03% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -8208.843% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -367142.317% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -51378.05% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -61532.829% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -6660.831% |
| PepGen Inc. | -60.67 Million USD | -18763.689% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -49711.107% |
| United Therapeutics Corporation | -507.7 Million USD | -2154.205% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -59737.917% |
| Solid Biosciences Inc. | -47.75 Million USD | -23867.749% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -1327442.748% |
| Immuneering Corporation | -54.94 Million USD | -20730.005% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -272164.367% |
| Silo Pharma, Inc. | -3.52 Million USD | -324633.253% |
| Belite Bio, Inc | -87.27 Million USD | -13013.864% |
| XOMA Corporation | -29 Million USD | -39364.138% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -16088.24% |
| Bionomics Limited | 227 Million USD | 5141.454% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -9742.108% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -451719.976% |
| uniQure N.V. | -102.95 Million USD | -11016.551% |
| Cassava Sciences, Inc. | -121.13 Million USD | -9347.728% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -274652.078% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 28047.059% |
| Forte Biosciences, Inc. | -11.96 Million USD | -95582.635% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -369772.665% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 10796892.453% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -352801.634% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 128618.81% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -154223.085% |
| Altimmune, Inc. | -134.48 Million USD | -8409.819% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 5878.204% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -451719.976% |
| Compugen Ltd. | -12.9 Million USD | -88590.329% |
| Peak Bio, Inc. | 10.34 Million USD | 110781.094% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -4043928.269% |
| Benitec Biopharma Inc. | -50.58 Million USD | -22525.835% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -10868.775% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 58357.063% |
| Zura Bio Limited | -99.8 Million USD | -11366.846% |
| PolyPid Ltd. | 6.17 Million USD | 185587.844% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 15540.637% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 58357.063% |
| Instil Bio, Inc. | 75.35 Million USD | 15286.974% |
| argenx SE | -2.02 Billion USD | -464.095% |
| Immunome, Inc. | -97.02 Million USD | -11695.03% |
| Verona Pharma plc | -220.44 Million USD | -5091.637% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -15852.218% |
| Shattuck Labs, Inc. | -121.42 Million USD | -9325.32% |
| CervoMed Inc. | -7.79 Million USD | -146760.338% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -6069.629% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -261610.496% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -8587.263% |
| Moolec Science SA | 117.61 Thousand USD | 9730578.846% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -500106.077% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 72085.951% |
| Design Therapeutics, Inc. | -18.15 Million USD | -62955.647% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -16160.923% |
| NeurAxis, Inc. | 145.7 Thousand USD | 7855007.344% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 101992.806% |
| Lumos Pharma, Inc. | -28.49 Million USD | -40066.357% |
| Achilles Therapeutics plc | -126.92 Million USD | -8916.892% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -15852.218% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -1745222.008% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -54991.443% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 784983.621% |
| Nutriband Inc. | -251.65 Thousand USD | -4547597.859% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -86792.415% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -153725.269% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 3464.11% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 48318.243% |
| MoonLake Immunotherapeutics | -447.47 Million USD | -2457.616% |
| Palisade Bio, Inc. | -12.06 Million USD | -94773.58% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -8056.595% |
| Beam Therapeutics Inc. | -262.72 Million USD | -4256.164% |
| Neurogene Inc. | -131.95 Million USD | -8573.108% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 52559.663% |
| AEON Biopharma, Inc. | -4.88 Million USD | -234420.492% |
| Sesen Bio, Inc. | -112.55 Million USD | -10068.187% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -11360.645% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -487362.055% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -29225.578% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -13641.985% |
| Athira Pharma, Inc. | -88.99 Million USD | -12759.246% |
| Vaccinex, Inc. | -1.28 Million USD | -888455.901% |
| HCW Biologics Inc. | 2.85 Million USD | 400726.462% |
| XOMA Corporation | -29 Million USD | -39364.138% |
| Nektar Therapeutics | 210.24 Million USD | 5543.588% |
| Arvinas, Inc. | -313.8 Million USD | -3547.1% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 705298.75% |
| Merus N.V. | -192.88 Million USD | -5833.411% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 19179.103% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -164855.319% |
| Rezolute, Inc. | -68.16 Million USD | -16688.816% |
| Clene Inc. | 3.34 Million USD | 342752.695% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -86686.987% |
| BeyondSpring Inc. | -13.75 Million USD | -83103.199% |
| Synlogic, Inc. | -6.68 Million USD | -171098.205% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 1009323.986% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -135258.959% |
| Peak Bio, Inc. | 10.34 Million USD | 110781.094% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -13785.707% |
| Krystal Biotech, Inc. | -350.23 Million USD | -3167.701% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 9320.222% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -6672.113% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -362398.511% |
| MannKind Corporation | 143.89 Million USD | 8053.217% |
| Ikena Oncology, Inc. | -109.15 Million USD | -10384.628% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -151063.651% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -34475.831% |
| Gossamer Bio, Inc. | 180.35 Million USD | 6445.596% |
| CohBar, Inc. | -5.93 Million USD | -192871.153% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -38371.83% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 250748.27% |
| Legend Biotech Corporation | -949.39 Million USD | -1105.459% |
| Mural Oncology plc | -255.84 Million USD | -4373.29% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 35625.687% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -242852.022% |
| Disc Medicine, Inc. | -358.28 Million USD | -3094.308% |
| Champions Oncology, Inc. | 4.81 Million USD | 237934.58% |
| REGENXBIO Inc. | 54.76 Million USD | 20996.509% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -4255869.536% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -7478.001% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -126892.814% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -14084.649% |
| Vaxart, Inc. | -8.24 Million USD | -138773.923% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -22707.109% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -8899.757% |
| Cellectis S.A. | -43.85 Million USD | -25996.454% |
| Longeveron Inc. | -2.9 Million USD | -393455.708% |
| Repare Therapeutics Inc. | -107.85 Million USD | -10510.803% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 1281.832% |
| Inozyme Pharma, Inc. | 12 Million USD | 95439.887% |
| Revolution Medicines, Inc. | -608.2 Million USD | -1781.704% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -930355.285% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | -4216.811% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -7526.073% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -73042.455% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -1546467.568% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | -19.665% |
| Denali Therapeutics Inc. | -74.86 Million USD | -15186.983% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -95337.67% |
| Veru Inc. | 4.77 Million USD | 239528.331% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -101665.961% |
| Cingulate Inc. | 3.08 Million USD | 371354.521% |
| Passage Bio, Inc. | 4.58 Million USD | 249709.597% |
| Context Therapeutics Inc. | -14.44 Million USD | -79102.332% |
| Exicure, Inc. | 5.84 Million USD | 195767.635% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -4867.792% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -28822.416% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 73037.353% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -19356.657% |
| Nuvalent, Inc. | -335.38 Million USD | -3312.356% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 659981.765% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -15265.592% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -128635.658% |
| OmniAb, Inc. | 9.2 Million USD | 124457.275% |
| Anew Medical, Inc. | 1.43 Million USD | 799044.477% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 69961.868% |
| Lipocine Inc. | -4.75 Million USD | -240606.248% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -10320.476% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 75240.175% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -22491.442% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 46077.021% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -170181.208% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -17285.875% |
| Ocugen, Inc. | -32.52 Million USD | -35091.415% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -13273.766% |
| Q32 Bio Inc. | -37.94 Million USD | -30058.638% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -1822288.535% |
| Alumis Inc. Common Stock | -13.52 Million USD | -84493.096% |
| Equillium, Inc. | -22.39 Million USD | -51010.218% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -44661.421% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -34977.333% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -4616240.278% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 8638.07% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 357967.417% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 3484622.334% |
| Dominari Holdings Inc. | 195 Thousand USD | 5869125.641% |
| Edesa Biotech, Inc. | -5.26 Million USD | -217192.492% |
| vTv Therapeutics Inc. | -8.91 Million USD | -128245.856% |
| Bio-Techne Corporation | 267.74 Million USD | 4374.408% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -70506.453% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -9591.094% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -136096.596% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -90363.995% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -4568.998% |
| Nkarta, Inc. | 57.29 Million USD | 20073.472% |
| BioCardia, Inc. | 212 Thousand USD | 5398496.226% |
| Iterum Therapeutics plc | 13.43 Million USD | 85265.947% |